A+
88/100
Intellia Therapeutics Claimed Company
Intellia Therapeutics is a leading genome editing company focused on developing proprietary, curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course, and through improved cell therapies that can treat cancer and immunological diseases, or can replace patients’ diseased cells. The combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts Intellia in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products. read more
HR or Marketing? Claim Your Free Employer Account
Intellia Therapeutics Compensation Employee Reviews
All
Positive
Constructive
What is the best part about your compensation package?
Salary is competitve and stock builds well over time
The compensation package is great in general, health packages, shutdowns 3 times a year and stock options are the best in the company.
Besides the competitive base salary, our medical benefits - our BCBS PPO has a really low employee premium and really great coverage.
Why do you feel undervalued and what would make you feel better about your compensation?
There aren't any Compensation reviews of Intellia Therapeutics yet.
Be the first to contribute a review.
×